Articles by Dr.James Ross
Neuroprotective Effects of Fraternine on Motor Neurons in Parkinson’s Disease Models
Disclaimer: All articles and product details provided on this website are intended for educational and informational purposes only. The products listed here are for in-vitro research only. In-vitro studies are conducted outside of living organisms. These products are not intended as medicines or drugs and have not been approved by the FDA to prevent, treat, or cure any medical condition, ailment, or disease. The direct or indirect administration of these substances to humans or animals is unequivocally prohibited under applicable law. Introduction Parkinson’s disease (PD) is a progressive neurodegenerative disorder that currently affects approximately one million individuals in the United...
Cdk5i-Based Therapeutic Strategy in Alzheimer’s Disease
Disclaimer: All articles and product details provided on this website are intended for educational and informational purposes only. The products listed here are for in-vitro research only. In-vitro studies are conducted outside of living organisms. These products are not intended as medicines or drugs and have not been approved by the FDA to prevent, treat, or cure any medical condition, ailment, or disease. The direct or indirect administration of these substances to humans or animals is unequivocally prohibited under applicable law. Background Cyclin-dependent kinase 5 (Cdk5) is a neuronal kinase activated by p35 and p39 cofactors. Under physiological conditions, Cdk5...
V24P Variant and Its Potential in Mitigating Amyloid Pathology in Alzheimer’s Disease
Disclaimer: All articles and product details provided on this website are intended for educational and informational purposes only. The products listed here are for in-vitro research only. In-vitro studies are conducted outside of living organisms. These products are not intended as medicines or drugs and have not been approved by the FDA to prevent, treat, or cure any medical condition, ailment, or disease. The direct or indirect administration of these substances to humans or animals is unequivocally prohibited under applicable law. Background on Amyloid Pathogenesis in Alzheimer’s Disease Alzheimer’s disease (AD) has long been associated with the accumulation of amyloid-β...
Curcumin-Loaded PLGA Nanoparticles: A Novel Strategy for Cognitive Enhancement and Neurogenesis in Alzheimer’s Disease
Disclaimer: All articles and product details provided on this website are intended for educational and informational purposes only. The products listed here are for in-vitro research only. In-vitro studies are conducted outside of living organisms. These products are not intended as medicines or drugs and have not been approved by the FDA to prevent, treat, or cure any medical condition, ailment, or disease. The direct or indirect administration of these substances to humans or animals is unequivocally prohibited under applicable law. Introduction Neurodegenerative disorders affect an estimated 1.5 billion individuals worldwide. A central pathological feature of these conditions is neuroinflammation,...
UB-312 as an Investigational Immunotherapy Targeting α-Synuclein in Parkinson’s Disease
Disclaimer: All articles and product details provided on this website are intended for educational and informational purposes only. The products listed here are for in-vitro research only. In-vitro studies are conducted outside of living organisms. These products are not intended as medicines or drugs and have not been approved by the FDA to prevent, treat, or cure any medical condition, ailment, or disease. The direct or indirect administration of these substances to humans or animals is unequivocally prohibited under applicable law. Introduction Alpha-synuclein (αSyn) is a neuronal protein localized at presynaptic terminals and involved in the regulation of neurotransmitter release....
Stay Ahead of the Curve
Get exclusive updates on events, promotions, and special offers.